drugset / Trial / NCT03085147

A Dye for the Detection of Cancer of the Tongue and Mouth

NCT03085147

Phase 1/2 Active not recruiting 23 enrolled Memorial Sloan Kettering Cancer Center
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to test if an investigational dye, called PARPi-FL, can be used to detect this type of cancer. This will be the first time that PARPi-FL is being tried in people. First, the investigators will test the safety of PARPi-FL at different doses to find out what effects, if any, it has on people. The investigators will also see which amount of PARPi-FL is best suited to detect cancers of the mouth and tongue.

Timeline

Start
2017-03-15
Primary completion
2026-07
Completion
2026-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Olaparib Small molecule 100 unknown Topical
Subject Olaparib Small molecule 250 unknown Topical
Subject Olaparib Small molecule 500 unknown Topical
Subject Olaparib Small molecule 1000 unknown Topical